CSAM Health Group AS
CSAMF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $121 | $115 | $10 | $104 |
| % Growth | 5% | 1,110.9% | -90.9% | – |
| Cost of Goods Sold | $8 | $9 | $7 | $8 |
| Gross Profit | $114 | $106 | $3 | $96 |
| % Margin | 93.7% | 92.1% | 29.2% | 92.6% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | -$1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $103 | $114 | $0 | $96 |
| Operating Expenses | $103 | $114 | -$1 | $96 |
| Operating Income | $11 | -$7 | $3 | -$4 |
| % Margin | 9.1% | -6.5% | 34.9% | -3.8% |
| Other Income/Exp. Net | -$4 | -$22 | -$3 | -$21 |
| Pre-Tax Income | $7 | -$29 | $1 | -$25 |
| Tax Expense | -$1 | $3 | -$0 | -$2 |
| Net Income | $8 | -$32 | $1 | -$24 |
| % Margin | 6.5% | -28% | 9.8% | -22.7% |
| EPS | 0.39 | -1.6 | 0.046 | -1.16 |
| % Growth | 124.4% | -3,563.2% | 104% | – |
| EPS Diluted | 0.39 | -1.6 | 0.046 | -1.16 |
| Weighted Avg Shares Out | 20 | 20 | 20 | 20 |
| Weighted Avg Shares Out Dil | 20 | 20 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | -$7 | $16 | -$6 |
| Interest Expense | $15 | $15 | $15 | $15 |
| Depreciation & Amortization | $16 | $13 | $1 | $14 |
| EBITDA | $37 | -$2 | $2 | $4 |
| % Margin | 30.8% | -1.3% | 21.9% | 4% |